<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="23511">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02800707</url>
  </required_header>
  <id_info>
    <org_study_id>1605M88288</org_study_id>
    <nct_id>NCT02800707</nct_id>
  </id_info>
  <brief_title>Sucralose, Stevia, Gut Microbiome and Glucose Metabolism</brief_title>
  <official_title>Sucralose, Stevia, Gut Microbiome and Glucose Metabolism</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Minnesota - Clinical and Translational Science Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Minnesota - Clinical and Translational Science Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will determine the influence of two non-caloric sweeteners on glucose metabolism
      via the gut microbiome in adult men and women.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will determine the influence of two non-caloric sweeteners on glucose metabolism
      via the gut microbiome in adult men and women.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>July 2016</start_date>
  <completion_date type="Anticipated">May 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single Blind (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>2-hour glucose</measure>
    <time_frame>14 days</time_frame>
    <description>An oral glucose tolerance test will be administered before and after consuming assigned sweetener to determine change in 2-hour glucose</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Gut microbiome</measure>
    <time_frame>14 days</time_frame>
    <description>Gut microbiota will be measured before and after consuming assigned sweetener to determine change in gut microbiota.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Impaired Glucose Tolerance</condition>
  <arm_group>
    <arm_group_label>Sucralose</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be asked to consume 180 mg/day of sucralose (in the form of capsules which is equivalent to three 12-oz cans of diet soda) for 14 days. According to the FDA, a 150 lb. person may consume up to 340 mg/day of sucralose (or 5.5 12-oz cans of sucralose-sweetened diet soda).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stevia</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Participants will be asked to consume 180 mg/day of stevia (in the form of capsules which is equivalent to three 12-oz cans of diet soda) for 14 days. According to the FDA, a 150 lb. person may consume up to 800 mg/day of stevia (or about 12 cans of stevia-sweetened diet soda).</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sucralose</intervention_name>
    <description>Sweetner</description>
    <arm_group_label>Sucralose</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Stevia</intervention_name>
    <description>Sweetner</description>
    <arm_group_label>Stevia</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: Generally health adult men and women aged 35-55 years old -

        Exclusion Criteria:Adults will not be eligible who have chronic disease (cancer, CHD,
        diabetes, chronic kidney disease); pregnant or breast feeding; menopausal; has a history
        of bariatric surgery; taking prednisone/steroids, taking medication for PCOS, or take
        medications that influence blood glucose.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lyn M Steffen, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Minnesota, MN</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Lyn M Steffen, PhD</last_name>
    <phone>612-625-9307</phone>
    <email>steffen@umn.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shalamar Sibley, MD</last_name>
    <email>sible004@umn.edu</email>
  </overall_contact_backup>
  <verification_date>June 2016</verification_date>
  <lastchanged_date>June 10, 2016</lastchanged_date>
  <firstreceived_date>June 10, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Individual data will not be made available.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
